Related Experiment Video
Updated: Feb 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Peripheral zone lesions of intermediary risk in multiparametric prostate MRI: Frequency and validation of the
Matthias Benndorf1, Lorenz Waibel1, Malte Krönig2
1Department of Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
Purpose:
To validate the risk stratification algorithm of the Prostate Imaging Reporting and Data System (PI-RADSv2) for intermediary risk lesions (PI-RADSv2 category 3) in the peripheral zone based on focal contrast enhancement and to compare cancer rates in category 3, upgraded category 4 and category 4 based on markedly low ADC value.
Materials And Methods:
We retrospectively analyze 172 consecutive patients undergoing prostate MRI with 315 histopathologically verified lesions. We select all lesions either assigned category 3 or category 4 in the peripheral zone for further analysis. We compare cancer rates with the two-sided chi-squared test. To determine inter-observer agreement about contrast enhancement two blinded radiologists evaluate the subset of category 3 lesions based on the diffusion weighted sequence.
Results:
The frequency of peripheral PI-RADS 3, upgraded PI-RADS 4 and PI-RADS 4 lesions based on markedly low ADC value is 10.8%, 10.8% and 20.3%, respectively. Cancer rates (significant cancer only) in these subgroups are 8.8% (3/34), 23.5% (8/34) and 40.6% (26/64), P < 0.01. Inter-observer agreement is moderate for evaluation of contrast enhancement with kappa values between 0.46 and 0.5.
Conclusion:
We demonstrate a trend of increasing cancer rate from PI-RADSv2 category 3 to upgraded category 4 to category 4 based on markedly low ADC value. Peripheral lesions of intermediary risk in the diffusion weighted sequence account for 21.6% of all prostate lesions encountered. Since it is likely that patient management recommendations will be linked to assessment categories in future versions of PI-RADS, cancer rates in upgraded category 4 and category 4 based on markedly low ADC values should be in a similar range. We conclude that in future studies of PI-RADSv2 upgraded category 4 and category 4 based on markedly low ADC value should be reported separately to generate a database for meta-analysis of cancer rates.
Insights
The Prostate Imaging Reporting and Data System (PI-RADSv2) algorithm shows a trend of increasing cancer rates for PI-RADSv2 category 3, upgraded category 4, and category 4 lesions. Separate reporting of upgraded category 4 and category 4 lesions is recommended for future meta-analyses.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- The Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) is used for prostate cancer risk stratification.
- Peripheral zone lesions with PI-RADSv2 category 3 represent an intermediate risk, requiring careful evaluation.
- Accurate risk assessment is crucial for guiding patient management and biopsy decisions.
Purpose of the Study:
- To validate the PI-RADSv2 risk stratification algorithm for intermediate-risk (category 3) peripheral zone lesions based on contrast enhancement.
- To compare cancer detection rates among PI-RADSv2 category 3, upgraded category 4, and category 4 lesions defined by markedly low apparent diffusion coefficient (ADC) values.
Main Methods:
- Retrospective analysis of 172 patients with 315 histopathologically verified prostate lesions.
- Inclusion of peripheral zone lesions categorized as PI-RADSv2 category 3 or 4.
- Comparison of cancer rates using the two-sided chi-squared test.
- Assessment of inter-observer agreement for contrast enhancement evaluation in category 3 lesions.
Main Results:
- Cancer rates were 8.8% for PI-RADSv2 category 3, 23.5% for upgraded category 4, and 40.6% for category 4 (based on low ADC value) (P < 0.01).
- Peripheral PI-RADS 3, upgraded PI-RADS 4, and PI-RADS 4 lesions represented 10.8%, 10.8%, and 20.3% of lesions, respectively.
- Moderate inter-observer agreement (kappa 0.46-0.5) was observed for contrast enhancement assessment.
Conclusions:
- A trend of increasing cancer rates was observed from PI-RADSv2 category 3 to upgraded category 4 to category 4 lesions.
- Peripheral intermediate-risk lesions (PI-RADSv2 category 3) constitute a significant proportion (21.6%) of all prostate lesions.
- Separate reporting of upgraded category 4 and category 4 lesions is recommended for future PI-RADSv2 versions to facilitate meta-analyses of cancer rates.
Related Concept Videos
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Drug Toxicity: Risk factors
Time and frequency -Domain Interpretation of PI Control
Acting as a low-pass filter, the PI controller slows the system's response and extends settling times. This requires...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Hybrid Zones

